Jump to content [Access key 'm'] Jump to site navigation [Access key 'n'] Jump to Contact Us and Glossary [Access key 's'] Jump to Site Services and Sitemap [Access key 's'] Jump to local navigation [Access key 'l']
 

Investors

Press Releases

If you would like to be alerted when a press release is added to this site, please register with the Alerting Service.



 

12/05/2000 Cyclacel Announces Collaboration with CV Therapeutics, Inc
11/03/2000 Cyclacel Appoints Dr. Athos Gianella-Borradori as Director, Medical Affairs
09/13/2000 Cyclacel Acquires the Assets of Fluorescience Limited
09/08/2000 Cyclacel Appoints Prof. Robert Westwood as Head of Preclinical Development
08/11/2000 Cyclacel Announces Patent Application for Improved Penetratin®
03/08/2000 Cyclacel Announces Major Cancer Genomics Initiative
02/24/2000 Cyclacel Announces Publication of Penetratin® Drug Conjugate Patent Application
01/18/2000 Cyclacel Appoints Dr Robert Jackson to Scientific Advisory Board
01/07/2000 Knighthood for Cyclacel's Top Scientist and Founder
Go to top  Go to top    Print page (opens in a new window)  Print page
 
Copyright © 1997-2008 Cyclacel Pharmaceuticals, Inc. All Rights Reserved  |  Site Map  |  Privacy  |  Disclaimer  |  Contact Us  |  Alerting Service